Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Κύριος συγγραφέας: | Forbes, E |
---|---|
Άλλοι συγγραφείς: | Hill, A |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
2011
|
Θέματα: |
Παρόμοια τεκμήρια
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
ανά: Kapulu, MC
Έκδοση: (2014) -
Developing novel blood-stage malaria vaccines
ανά: Douglas, AD
Έκδοση: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
ανά: Bauza, K
Έκδοση: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
ανά: de Cassan, S
Έκδοση: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
ανά: Elias, SC
Έκδοση: (2014)